These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 26450404)
1. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications. Conde-Agudelo A; Romero R Am J Obstet Gynecol; 2016 Feb; 214(2):235-242. PubMed ID: 26450404 [TBL] [Abstract][Full Text] [Related]
2. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis. Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885 [TBL] [Abstract][Full Text] [Related]
3. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Romero R; Nicolaides KH; Conde-Agudelo A; O'Brien JM; Cetingoz E; Da Fonseca E; Creasy GW; Hassan SS Ultrasound Obstet Gynecol; 2016 Sep; 48(3):308-17. PubMed ID: 27444208 [TBL] [Abstract][Full Text] [Related]
4. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Romero R; Conde-Agudelo A; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Nicolaides KH Am J Obstet Gynecol; 2018 Feb; 218(2):161-180. PubMed ID: 29157866 [TBL] [Abstract][Full Text] [Related]
5. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in twin gestations: a systematic review and meta-analysis. Conde-Agudelo A; Romero R; Rehal A; Brizot ML; Serra V; Da Fonseca E; Cetingoz E; Syngelaki A; Perales A; Hassan SS; Nicolaides KH Am J Obstet Gynecol; 2023 Dec; 229(6):599-616.e3. PubMed ID: 37196896 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update. Werner EF; Hamel MS; Orzechowski K; Berghella V; Thung SF Am J Obstet Gynecol; 2015 Oct; 213(4):554.e1-6. PubMed ID: 26071914 [TBL] [Abstract][Full Text] [Related]
7. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data. Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007 [TBL] [Abstract][Full Text] [Related]
8. Utility of follow-up cervical length screening in low-risk women with a cervical length of 26 to 29 mm. Boelig RC; Kripalu V; Chen SL; Cruz Y; Roman A; Berghella V Am J Obstet Gynecol; 2021 Aug; 225(2):179.e1-179.e6. PubMed ID: 33652056 [TBL] [Abstract][Full Text] [Related]
9. SMFM Consult Series #70: Management of short cervix in individuals without a history of spontaneous preterm birth. ; Biggio J; Am J Obstet Gynecol; 2024 Aug; 231(2):B2-B13. PubMed ID: 38754603 [TBL] [Abstract][Full Text] [Related]
10. Treatment options and recommendations to reduce preterm births in women with short cervix. Slager J; Lynne S J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244 [TBL] [Abstract][Full Text] [Related]
11. Rationale and design of SuPPoRT: a multi-centre randomised controlled trial to compare three treatments: cervical cerclage, cervical pessary and vaginal progesterone, for the prevention of preterm birth in women who develop a short cervix. Hezelgrave NL; Watson HA; Ridout A; Diab F; Seed PT; Chin-Smith E; Tribe RM; Shennan AH BMC Pregnancy Childbirth; 2016 Nov; 16(1):358. PubMed ID: 27871275 [TBL] [Abstract][Full Text] [Related]
12. Preventing Preterm Birth with Progesterone in Women with a Short Cervical Length from a Low-Risk Population: A Multicenter Double-Blind Placebo-Controlled Randomized Trial. van Os MA; van der Ven AJ; Kleinrouweler CE; Schuit E; Kazemier BM; Verhoeven CJ; de Miranda E; van Wassenaer-Leemhuis AG; Sikkema JM; Woiski MD; Bossuyt PM; Pajkrt E; de Groot CJ; Mol BW; Haak MC Am J Perinatol; 2015 Aug; 32(10):993-1000. PubMed ID: 25738790 [TBL] [Abstract][Full Text] [Related]
13. Cervical elastography in predicting spontaneous preterm birth in singleton pregnancy with a short cervix receiving progesterone treatment at 18 to 24 weeks' gestation. He B; Zhou Y; Cao L; Yao B; Gao H; Zhang H J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2347954. PubMed ID: 38714523 [TBL] [Abstract][Full Text] [Related]
15. Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. Conde-Agudelo A; Romero R; Nicolaides K; Chaiworapongsa T; O'Brien JM; Cetingoz E; da Fonseca E; Creasy G; Soma-Pillay P; Fusey S; Cam C; Alfirevic Z; Hassan SS Am J Obstet Gynecol; 2013 Jan; 208(1):42.e1-42.e18. PubMed ID: 23157855 [TBL] [Abstract][Full Text] [Related]
16. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial. Rehal A; Benkő Z; De Paco Matallana C; Syngelaki A; Janga D; Cicero S; Akolekar R; Singh M; Chaveeva P; Burgos J; Molina FS; Savvidou M; De La Calle M; Persico N; Quezada Rojas MS; Sau A; Greco E; O'Gorman N; Plasencia W; Pereira S; Jani JC; Valino N; Del Mar Gil M; Maclagan K; Wright A; Wright D; Nicolaides KH Am J Obstet Gynecol; 2021 Jan; 224(1):86.e1-86.e19. PubMed ID: 32598909 [TBL] [Abstract][Full Text] [Related]
17. Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening. Enakpene CA; DiGiovanni L; Jones TN; Marshalla M; Mastrogiannis D; Della Torre M Am J Obstet Gynecol; 2018 Oct; 219(4):397.e1-397.e10. PubMed ID: 30017683 [TBL] [Abstract][Full Text] [Related]
18. Cervical pessary versus vaginal progesterone in women with a singleton pregnancy, a short cervix, and no history of spontaneous preterm birth at less than 34 weeks' gestation: open label, multicentre, randomised, controlled trial. van Dijk CE; van Gils AL; van Zijl MD; Koullali B; van der Weide MC; van den Akker ES; Hermsen BJ; van Baal WM; Visser H; van Drongelen J; Vollebregt KC; Muller M; van der Made FW; Gordijn SJ; de Mooij YM; Oudijk MA; de Boer MA; Mol BW; Kazemier BM; Pajkrt E; BMJ; 2024 Mar; 384():e077033. PubMed ID: 38471724 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of cervical length screening and progesterone treatment to prevent spontaneous preterm delivery in Sweden. Wikström T; Kuusela P; Jacobsson B; Hagberg H; Lindgren P; Svensson M; Wennerholm UB; Valentin L Ultrasound Obstet Gynecol; 2022 Jun; 59(6):778-792. PubMed ID: 35195310 [TBL] [Abstract][Full Text] [Related]
20. Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety. El-Refaie W; Abdelhafez MS; Badawy A Arch Gynecol Obstet; 2016 Jan; 293(1):61-67. PubMed ID: 26044148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]